Be a Smart Investor
Wednesday, February 15, 2017
AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO
Axsome Therapeutics Inc.'s (AXSM) drug candidate AXS-05 has received Fast Track status from the FDA for treatment resistant depression.
from RTT - Biotech http://ift.tt/2lguu3o
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment